Trial Profile
The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2023
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms NOMI
- Sponsors INO Therapeutics; Mallinckrodt plc
- 23 Apr 2023 This trial has been completed in Hungary (End date: 01 May 2016).
- 02 Aug 2022 This trial has been completed in Belgium, according to European Clinical Trials Database record.
- 30 Jun 2012 Planned patient number is 230 according to European Clinical Trials Database.